Humanization of an anti-mucin antibody for breast and ovarian cancer therapy. by Baker, T, Bose, C, Caskey-Finney, H, King, D, Lawson, A, Lyons, A, Mountain, A, Owens, R, Rolfe, MR, Sehdev, M

TUMOR BINDING-PROPERTIES OF B72.3 FV FRAGMENTS by Owens, R, King, D, Howat, D, Lisle, H, Mountain, A, Harvey, A, Bergin, S, Turner, A, Pedley, B, Boden, J, Begent, R, Yarranton, G

TUMOR-LOCALIZATION OF ENGINEERED ANTIBODY FRAGMENTS by King, D, Mountain, A, Adair, J, Owens, R, Harvey, A, Weir, N, Proudfoot, K, Phipps, A, Lawson, A, Rhind, S, Pedley, B, Boden, J, Boden, R, Begent, R, Yarranton, G

Nitroreductase: a prodrug-activating enzyme for cancer gene therapy. by Searle, P, Chen, M, Hu, L, Race, P, Lovering, A, Grove, J, Guise, C, Jaberipour, M, James, N, Mautner, V, Young, L, Kerr, D, Mountain, A, White, SA, Hyde, E

Virus-directed enzyme prodrug therapy: intratumoral administration of a replication-deficient adenovirus encoding nitroreductase to patients with resectable liver cancer. by Palmer, D, Mautner, V, Mirza, D, Oliff, S, Gerritsen, W, van der Sijp, JR, Hubscher, S, Reynolds, G, Bonney, S, Rajaratnam, R, Hull, D, Horne, M, Ellis, J, Mountain, A, Hill, S, Harris, P, Searle, P, Young, L, James, N, Kerr, D